The Tapestri Platform provides an unprecedented level of quantification of DNA integrations in significantly less time compared to other techniques such as qPCR and does so at single cell resolution. These characteristics allow for the rapid optimization of transduction protocols or homology directed repair (HDR) protocols during therapy development and streamlined testing and release of transduced or integrated cells during manufacturing of therapeutic products.